Putting Advanced Cardiovascular Testing into Practice

​Heart disease is the leading cause of death for both men and women in the United States. 

​Lipid profiles have been a cornerstone of heart disease prevention. While it is common to use LDL “bad” and HDL “good” cholesterol measurements to determine a patient’s risk for heart disease, this approach only shows the “tip of the iceberg”. A comprehensive approach to risk stratification should include newer markers to personalize a patient’s risk assessment and create an opportunity for an actionable plan. Learn how advanced testing can help in identifying risk and assist with management plans.

​Join us on February 21 as Dr. Regina Druz, MD provides an overview of advanced cardiovascular testing options